Merck and Cambridge-based Moderna reported in August that adding their mRNA cancer vaccine to an existing treatment slowed the return and spread of melanoma. The field had been waiting with bated bre… [+4887 chars]
Merck and Cambridge-based Moderna reported in August that adding their mRNA cancer vaccine to an existing treatment slowed the return and spread of melanoma. The field had been waiting with bated bre… [+4887 chars]
Post Your Take